Axcelis Technologies (ACLS) Scheduled to Post Quarterly Earnings on Wednesday

Axcelis Technologies (NASDAQ:ACLS) is set to issue its quarterly earnings data after the market closes on Wednesday, July 31st. Analysts expect the company to announce earnings of $1.39 per share for the quarter. Axcelis Technologies has set its Q2 guidance at $1.30 EPS and its Q2 2024 guidance at 1.300-1.300 EPS.Parties interested in listening to the company’s conference call can do so using this link.

Axcelis Technologies (NASDAQ:ACLS) last issued its quarterly earnings data on Wednesday, May 1st. The semiconductor company reported $1.57 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.26 by $0.31. Axcelis Technologies had a return on equity of 30.22% and a net margin of 22.16%. The business had revenue of $252.37 million during the quarter, compared to analyst estimates of $242.55 million. On average, analysts expect Axcelis Technologies to post $7 EPS for the current fiscal year and $8 EPS for the next fiscal year.

Axcelis Technologies Price Performance

Shares of ACLS opened at $122.99 on Tuesday. The firm has a market capitalization of $4.00 billion, a PE ratio of 16.25, a P/E/G ratio of 1.78 and a beta of 1.60. The stock has a 50 day simple moving average of $131.70 and a 200 day simple moving average of $120.30. The company has a debt-to-equity ratio of 0.05, a quick ratio of 2.87 and a current ratio of 4.00. Axcelis Technologies has a 52-week low of $93.77 and a 52-week high of $201.00.

Insider Transactions at Axcelis Technologies

In other news, Director John T. Kurtzweil sold 1,200 shares of the company’s stock in a transaction that occurred on Monday, May 20th. The stock was sold at an average price of $114.42, for a total transaction of $137,304.00. Following the sale, the director now owns 33,146 shares in the company, valued at approximately $3,792,565.32. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Company insiders own 1.43% of the company’s stock.

Wall Street Analysts Forecast Growth

ACLS has been the topic of several research reports. Benchmark boosted their target price on Axcelis Technologies from $170.00 to $180.00 and gave the company a “buy” rating in a research note on Monday, July 15th. Bank of America boosted their target price on Axcelis Technologies from $125.00 to $150.00 and gave the company a “neutral” rating in a research note on Wednesday, July 10th. DA Davidson boosted their target price on Axcelis Technologies from $150.00 to $175.00 and gave the company a “buy” rating in a research note on Monday, July 15th. B. Riley boosted their target price on Axcelis Technologies from $175.00 to $190.00 and gave the company a “buy” rating in a research note on Friday, July 12th. Finally, Needham & Company LLC restated a “hold” rating on shares of Axcelis Technologies in a research note on Friday, July 12th. Three investment analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $172.33.

About Axcelis Technologies

Axcelis Technologies, Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia Pacific. The company offers high energy, high current, and medium current implanters for various application requirements.